Humacyte Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
/ 
Frequently asked questions
To buy Humacyte Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Humacyte Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Humacyte Inc. is HUMA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Humacyte Inc. has its primary listing on NASDAQ. You can trade Humacyte Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Humacyte Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Humacyte Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Humacyte Inc..